Bruker Biospin Corp

Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC headquartered in Billerica, Massachusetts, is a manufacturer of advanced scientific instruments specializing in nuclear magnetic resonance (NMR) spectrometers, magnetic resonance imaging (MRI) systems, and electron spin resonance (EPR) spectrometers. The company provides comprehensive support to federal agencies through the design, manufacture, distribution, installation, maintenance, and repair of sophisticated analytical and diagnostic equipment critical to scientific research and medical operations across government laboratories and healthcare facilities.

Bruker Biospin Corp maintains an extensive federal contracting presence across numerous civilian and defense agencies, with a robust portfolio of prime contract awards spanning equipment procurement, maintenance services, and technical support. The company has delivered major scientific instruments including high-field MRI scanners, NMR spectrometers at various frequencies (400 MHz, 500 MHz, 600 MHz, 700 MHz, 800 MHz, and 11.7 Tesla systems), microCT imaging systems, and specialized analytical equipment to agencies including the National Institutes of Health and its component institutes (National Institute on Drug Abuse, National Institute of Mental Health, National Cancer Institute, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases, National Heart Lung and Blood Institute, National Institute of Child Health and Human Development, National Institute of Neurological Disorders and Stroke, and others), the Food and Drug Administration, Department of Veterans Affairs, Department of Defense entities, National Institute of Standards and Technology, NASA, the U.S. Army Corps of Engineers, Naval Sea Systems Command, and various other federal research and testing facilities. Beyond equipment sales, Bruker Biospin Corp provides extensive maintenance and support services, including preventive maintenance agreements, repair services, helium refill services, cryogenic system maintenance, software upgrades, technical support, and equipment upgrades. Recent notable prime contracts include a $2.9 billion Naval Sea Systems Command award for AVANCE NMR spectrometers, a $2.8 billion National Institute of Biomedical Imaging and Bioengineering contract for high-field MRI scanners, a $2.3 billion National Institute of Standards and Technology order for 600 MHz NMR spectrometer systems, and multiple seven-figure maintenance and service agreements across the NIH enterprise. All prime contract awards identified were awarded on a full and open competition basis with no set-aside designations, reflecting Bruker's competitive standing as a qualified sole-source provider of proprietary equipment and the associated technical expertise required for specialized scientific instrument support. Bruker Biospin Corp has also been engaged as a subcontractor through prime contractors including Leidos, Inc., Leidos Biomedical Research Inc., Triad National Security LLC, Honeywell Federal Manufacturing & Technologies LLC, and Consolidated Nuclear Security LLC, providing specialized laboratory equipment, materials, and maintenance services in support of broader federal research and national security programs.

Bruker Biospin Corp's federal grant activity has focused on collaborative research partnerships with academic institutions working on federally funded research initiatives. The company has served as a subgrantee under awards from the University of Denver, participating in National Institutes of Health-funded research focused on developing benchtop pulse and rapid scan preclinical electron paramagnetic resonance imaging technology. In this partnership, which began in 2021 and continued through 2024, Bruker provided technical expertise, equipment development support, and commercialization guidance to convert research prototypes into marketable products. The collaboration leveraged Ralph Weber's expertise at Bruker to guide prototype development in Denver toward commercial standards applicable to Bruker's manufacturing and maintenance capabilities. This subgrant work demonstrates Bruker's involvement in the NIH research ecosystem beyond traditional procurement contracts, contributing technical innovation and manufacturing expertise to advance preclinical imaging capabilities that could expand the implementation of in vivo EPR imaging and other advanced analytical techniques. The grant subcontract relationship showcases how Bruker utilizes its scientific expertise and commercial manufacturing capabilities to support the federal research community's efforts to develop next-generation diagnostic and research instrumentation.